Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca
Condition(s):Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction AdenocarcinomaLast Updated:June 10, 2021Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction AdenocarcinomaLast Updated:June 10, 2021Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:January 23, 2024Recruiting
Condition(s):Cerebral Palsy; Hemiplegic Cerebral PalsyLast Updated:February 28, 2024Recruiting
Condition(s):Cerebral Palsy; Hemiplegic Cerebral PalsyLast Updated:December 21, 2023Recruiting
Condition(s):Open Angle GlaucomaLast Updated:March 15, 2024Recruiting
Condition(s):Health and Wellbeing of Occupational Therapy StudentsLast Updated:February 2, 2024Recruiting
Condition(s):Chronic BronchitisLast Updated:November 7, 2023Recruiting
Condition(s):Cytokine Release SyndromeLast Updated:October 25, 2023Recruiting
Condition(s):Preeclampsia Severe; Cardiovascular Diseases; Primary PreventionLast Updated:May 22, 2023Recruiting
Condition(s):Heart FailureLast Updated:March 26, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.